Literature DB >> 15254879

High glucose augments arginase activity and nitric oxide production in the renal cortex.

Naohito Ishii1, Hideki Ikenaga, Pamela K Carmines, Yoshikazu Aoki, Zensuke Ogawa, Takao Saruta, Tetsuya Suga.   

Abstract

To clarify the interaction between arginase and nitric oxide (NO) production in the kidney with normal and high glucose levels, renal cortical slices from male Sprague-Dawley rats were incubated in Hank's solution containing various concentrations of L-norvaline (Nval; an arginase inhibitor), 500 U/mL superoxide dismutase, and either 5 mmol/L (normal) or 20 mmol/L (high) glucose (n = 5 per group). Incubation with Nval increased renal cortical NOX (nitrite + nitrate) production dose-dependently, indicating competition between arginase and NO synthase (NOS) for the substrate (L-arginine). In the basal condition without Nval, high glucose also increased NO(X) production to a rate 3 times that observed during incubation with normal glucose (P < .01). This effect of high glucose was not altered by Nval. Rather, the effects of high glucose and Nval were additive, indicating that the activity of NOS per se is enhanced by high glucose. Direct assay of arginase and NOS activities confirmed stimulation of both enzymes under the high glucose condition (P < .05, P < .01, v normal glucose, respectively). However, high glucose did not change the amount of L-arginine present in renal cortical slices. These data reveal that arginase competes with NOS for L-arginine in the renal cortex, and that high glucose increases the activity of both enzymes without affecting the amount of substrate. These results suggest that increased NOS activity, rather than altered substrate availability, may be the principal factor underlying increased NO synthesis in diabetic kidneys.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254879     DOI: 10.1016/j.metabol.2004.02.011

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  4 in total

1.  Effect of in vitro glucose and diabetic hyperglycemia on mouse kidney protein synthesis: relevance to diabetic microangiopathy.

Authors:  Silvia Iannello; Paolina Milazzo; Fabio Bordonaro; Francesco Belfiore
Journal:  MedGenMed       Date:  2005-09-07

2.  1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics.

Authors:  Gesiane Tavares; Gabriela Venturini; Kallyandra Padilha; Roberto Zatz; Alexandre C Pereira; Ravi I Thadhani; Eugene P Rhee; Silvia M O Titan
Journal:  Metabolomics       Date:  2018-02-27       Impact factor: 4.290

3.  Effect of rosuvastatin on arginase enzyme activity and polyamine production in experimental breast cancer.

Authors:  Hakan Erbaş; Oğuz Bal; Erol Çakır
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

4.  Insulin reduces plasma arginase activity in type 2 diabetic patients.

Authors:  Sangeeta R Kashyap; Abigail Lara; Renliang Zhang; Young Mi Park; Ralph A DeFronzo
Journal:  Diabetes Care       Date:  2007-10-10       Impact factor: 19.112

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.